ÎÚÑ»´«Ã½

GlaxoSmithKline K.K.
ÎÚÑ»´«Ã½.

GlaxoSmithKline K.K. (Head Office: Tokyo, President: Marc Dunoyer) and ÎÚÑ»´«Ã½. (Headquarters: Tokyo, President and CEO: Haruo Naito) announce that they have agreed to terminate their alliance to market Breathe Right® nasal strips, manufactured by GlaxoSmithKline group and marketed in Japan by ÎÚÑ»´«Ã½, as of 31 May 2008. As a result, GlaxoSmithKline K.K. will market the product in Japan from 1 June 2008.

Breathe Right® nasal strips contain plastic bands that improve nasal breathing. The reflex action of the two plastic bands embedded into the strips open nasal passages. The Breathe Right® series are appropriate for relieving nasal congestion such as at the turn of the season, when snoring is a problem and for increasing the amount of oxygen intake when playing sports.

Breathe Right® has been marketed in Japan by ÎÚÑ»´«Ã½ from October 2000. In December 2006, GlaxoSmithKline group acquired US-based CNS, which had been manufacturing Breathe Right®. Since then GlaxoSmithKline has been manufacturing the product for Japan and supplying it to ÎÚÑ»´«Ã½. Following the expiration of the marketing alliance contract, it was decided after discussion between both companies that GlaxoSmithKline K.K. would market this brand in Japan.